influenza
virus
wide
host
rang
infect
wild
waterfowl
poultri
human
recent
crossspeci
transmiss
avian
influenza
particularli
subtyp
highlight
import
nonhuman
subtyp
incid
human
popul
increas
past
decad
crossspeci
transmiss
human
diseas
rang
asymptomat
mild
conjunct
fulmin
pneumonia
death
case
howev
risk
genet
chang
develop
novel
viru
increas
heighten
need
public
health
hospit
measur
review
discuss
epidemiolog
host
rang
human
diseas
outcom
treatment
prevent
crosstransmiss
avian
influenza
human
ard
acut
respiratori
distress
syndrom
cdc
center
diseas
control
prevent
ha
hemagglutinin
hpai
highli
pathogen
avian
influenza
na
neuroaminidas
world
health
organ
human
influenza
pandem
last
year
caus
subtyp
influenza
virus
recent
avian
influenza
viru
subtyp
found
directli
infect
human
avian
host
recent
emerg
host
expans
spread
highli
pathogen
avian
influenza
hpai
subtyp
asia
heighten
concern
global
regard
mortal
hpai
infect
human
potenti
new
pandem
paper
review
current
human
infect
avian
influenza
public
health
medic
implic
influenza
b
c
import
genera
orthomyxovirida
famili
casus
pandem
season
diseas
human
influenza
virus
envelop
singlestrand
rna
virus
segment
genom
tabl
classifi
subtyp
basi
antigen
properti
hemagglutinin
ha
neuraminidas
na
glycoprotein
express
surfac
viru
influenza
virus
character
pathogen
highli
pathogen
avian
influenza
hpai
caus
sever
diseas
death
domest
poultri
molecular
chang
rna
genom
occur
two
main
mechan
point
mutat
antigen
drift
rna
segment
reassort
antigen
shift
point
mutat
caus
minor
chang
antigen
charact
virus
primari
reason
vaccin
influenza
given
yearli
reassort
occur
host
cell
infect
two
influenza
virus
lead
creation
novel
subtyp
influenza
subtyp
pandem
occur
reassort
origin
pandem
unclear
ha
glycoprotein
mediat
attach
entri
viru
bind
sialic
acid
receptor
cell
surfac
bind
affin
ha
host
sialic
acid
allow
host
specif
influenza
avian
influenza
subtyp
prefer
bind
sialic
acid
link
galactos
linkag
found
avian
intestin
respiratori
epithelium
tabl
human
viru
subtyp
bind
linkag
found
human
respiratori
epithelium
swine
contain
linkag
respiratori
epithelium
allow
easi
coinfect
human
avian
subtyp
thu
act
mix
vessel
new
strain
human
found
contain
linkag
lower
respiratori
tract
conjunctiva
allow
human
infect
avian
subtyp
ha
glycoprotein
main
target
immun
neutral
antibodi
na
glycoprotein
allow
spread
viru
cleav
glycosid
linkag
sialic
acid
host
cell
surfac
viru
viru
spread
secret
bodili
fluid
na
glycoprotein
major
target
site
neutral
viru
antibodi
influenza
virus
infect
wide
rang
host
includ
mani
avian
speci
variou
mammalian
speci
swine
ferret
felid
mink
whale
hors
seal
dog
civet
human
wild
bird
duck
gees
swan
shorebird
import
natur
reservoir
virus
known
ha
na
subtyp
found
bird
case
subtyp
found
within
gastrointestin
tract
bird
shed
fece
rare
caus
diseas
sinc
howev
hpai
virus
origin
asia
report
approxim
wild
bird
speci
caus
diseas
instanc
asymptomat
shed
other
viru
spread
across
asia
europ
middl
east
african
countri
addit
speci
tiger
leopard
cat
stone
marten
human
also
becom
infect
hpai
spread
wide
rang
anim
avian
speci
may
enhanc
spread
viru
human
popul
interact
anim
number
way
increas
land
use
market
consumpt
thu
potenti
contact
transmiss
mutabl
hpai
worldwid
increas
number
speci
interact
increas
complic
prevent
surveil
treatment
possibl
incid
avian
influenza
infect
human
increas
past
decad
tabl
initi
case
avian
influenza
human
occur
associ
poultri
outbreak
manifest
selflimit
conjunct
larg
scale
hpai
outbreak
occur
among
poultri
hong
kong
document
human
case
two
subsequ
poultri
outbreak
hong
kong
hpai
occur
without
human
case
two
member
famili
hong
kong
contract
hpai
decemb
hpai
surfac
poultri
korea
china
outbreak
stretch
worldwid
largest
outbreak
poultri
histori
human
case
hpai
follow
poultri
outbreak
total
case
fatal
thu
far
limit
outbreak
occur
caus
variabl
human
diseas
tabl
howev
hpai
remain
largest
signific
poultri
human
avian
influenza
outbreak
epidemiolog
investig
human
case
avian
influenza
show
viru
acquir
direct
contact
infect
bird
influenza
transmit
fecalor
respiratori
rout
among
wild
bird
poultri
human
interact
infect
secret
bird
major
mode
transmiss
contact
includ
consumpt
undercook
raw
poultri
product
handl
sick
dead
bird
without
protect
food
process
bird
clean
site
bird
domest
chicken
duck
goos
transmiss
bird
wild
migrat
contamin
waterway
document
case
limit
human
human
transmiss
report
among
health
care
worker
famili
member
tabl
case
person
protect
equip
use
major
factor
transmiss
human
clinic
manifest
avian
influenza
human
rang
mild
conjunct
sever
pneumonia
multiorgan
system
failur
howev
hpai
hong
kong
southeast
asia
current
pneumonia
progress
multiorgan
failur
acut
respiratori
distress
syndrom
ard
death
predomin
find
rye
syndrom
pulmonari
hemorrhag
predomin
nausea
vomit
diarrhea
complic
case
laboratori
find
includ
thrombocytopenia
lymphopenia
chest
radiograph
find
includ
interstiti
infiltr
lobar
consolid
air
bronchogram
clinic
cours
patient
hpai
rapid
percent
patient
develop
ard
multiorgan
failur
within
day
diseas
onset
case
fatal
rate
rang
form
depend
case
seri
patient
reach
critic
care
unit
howev
mortal
rate
averag
time
death
diseas
onset
nine
ten
day
avian
influenza
infect
human
differ
season
influenza
sever
way
presenc
conjunct
avail
onlin
http
number
fatal
percent
h
hemagglutinin
ili
influenza
like
ill
n
neuroaminidas
common
avian
influenza
infect
season
influenza
gastrointestin
symptom
seen
hpai
report
primari
influenza
pneumonia
develop
ard
also
common
avian
influenza
infect
final
rapid
progress
multiorgan
failur
eventu
death
occur
much
higher
rate
avian
influenza
infect
postmortem
studi
illustr
find
consist
overwhelm
system
inflammatori
respons
syndrom
includ
diffus
alveolar
damag
acut
tubular
necrosi
atrophi
dissemin
intravascular
coagul
multiorgan
damag
interestingli
viru
isol
lung
intestin
spleen
brain
suggest
viremia
activ
replic
viru
limit
lung
overwhelm
inflammatori
respons
acut
lung
injuri
ard
predomin
featur
coincid
find
preferenti
bind
avian
influenza
virus
linkag
type
ii
pneumocyt
lower
respiratori
tract
human
vigor
cytokin
respons
includ
increas
interferon
beta
releas
clinic
diagnosi
avian
influenza
infect
human
difficult
reli
epidemiolog
link
endem
area
contact
sick
dead
poultri
contact
confirm
case
avian
influenza
tabl
sinc
mani
infecti
diseas
present
similar
symptom
featur
signific
clinician
may
contact
endem
area
travel
infect
poultri
clinician
alway
elicit
detail
patient
histori
definit
diagnosi
made
isol
viru
cultur
clinic
specimen
method
provid
definit
diagnosi
viral
isol
avail
test
includ
pathogen
antivir
resist
dna
sequenc
analysi
altern
antibodi
test
perform
standard
fourfold
titer
increas
specif
subtyp
avian
influenza
viru
neutral
antibodi
titer
assay
perform
micorneutr
techniqu
western
blot
analysi
recombin
confirmatori
test
posit
microneutr
assay
recent
rapid
diagnosi
perform
revers
transcriptionpcr
clinic
sampl
primer
specif
viral
subtyp
test
perform
patient
meet
case
definit
possibl
avian
influenza
infect
suspect
case
avian
influenza
human
investig
public
health
offici
provinc
countri
origin
addit
government
lab
often
equip
appropri
biolevel
safeti
laboratori
primer
librari
associ
expertis
confirm
diagnosi
quickli
effici
clinic
specimen
submit
assist
public
health
expert
treatment
avian
influenza
infect
human
includ
antivir
therapi
support
care
control
clinic
trial
efficaci
antivir
na
inhibitor
support
therapi
adjuv
care
never
perform
current
recommend
stem
experi
past
avian
influenza
outbreak
anim
model
adamantan
rimantadin
amantadin
na
inhibitor
oseltamivir
zanamivir
antivir
use
treatment
prophylaxi
influenza
infect
human
avian
influenza
viru
infect
adamantan
role
due
widespread
resist
protein
alter
addit
isol
human
subtyp
season
influenza
resist
adamantan
role
limit
prophylaxi
commun
circul
strain
know
suscept
adamantan
na
inhibitor
oseltamivir
zanamivir
studi
treatment
prophylaxi
human
influenza
subtyp
well
influenza
b
tabl
anim
model
hpai
efficaci
well
document
improv
surviv
rate
seen
infect
oseltamivir
use
avian
influenza
outbreak
involv
hpai
therapi
oseltamivir
shown
decreas
viral
load
nasal
secret
patient
infect
hpai
resist
oseltamivir
document
hpai
subtyp
vietnames
girl
treat
mg
daili
day
postexposur
prophylaxi
na
glycoprotein
histidin
tyrosin
substitut
posit
convey
markedli
higher
oseltamivir
one
studi
viral
count
hpai
nasal
secret
decreas
administr
oseltamivir
isol
carri
resist
mutat
howev
resist
produc
chang
may
overcom
higher
dose
oseltamivir
vitro
chang
document
confer
resist
zanamivir
time
treatment
na
inhibitor
paramount
earli
therapi
directli
relat
improv
surviv
greatest
level
protect
seen
na
inhibitor
start
within
hour
infect
protect
rapidli
drop
hour
initi
studi
howev
perform
season
human
influenza
b
period
viral
shed
approxim
hour
hpai
case
southeast
asia
surviv
appear
improv
patient
receiv
oseltamavir
earlier
day
versu
day
onset
symptom
time
period
much
longer
document
anim
model
window
optim
therapi
still
unknown
particularli
viral
shed
exce
averag
hour
period
seen
season
influenza
b
infect
combin
therapi
influenza
virus
studi
ribaviron
inhal
evalu
vitro
avian
influenza
subtyp
found
reduc
mortal
influenza
b
mous
model
anim
model
studi
indic
determin
role
ribaviron
combin
therapi
avian
influenza
virus
support
care
intraven
rehydr
mechan
ventil
vasopressor
therapi
renal
replac
therapi
requir
multiorgan
failur
ard
featur
diseas
due
progress
pneumonia
ard
noninvas
ventil
recommend
earli
intub
may
benefici
overt
respiratori
failur
ensu
corticosteroid
use
patient
hpai
definit
role
steroid
determin
immunomodulatori
therapi
report
human
vaccin
avian
influenza
virus
wide
use
although
multipl
vaccin
trial
underway
prior
avian
vaccin
human
poorli
immunogen
thu
limit
use
inactiv
test
toler
limit
immunogen
vaccin
result
develop
neutral
antibodi
limit
degre
recent
larg
random
trial
look
attenu
vaccin
vietnam
strain
modest
immun
respons
seen
microneutr
antibodi
develop
time
dose
use
season
influenza
vaccin
side
effect
minim
number
industri
trial
adjuv
vaccin
current
ongo
although
promis
human
vaccin
avian
influenza
virus
still
develop
underscor
develop
uncertainti
pandem
strain
may
vastli
differ
antigen
properti
develop
vaccin
health
care
infect
control
crucial
compon
manag
avian
influenza
infect
new
pandem
strain
experi
sever
ard
outbreak
illustr
appropri
infect
control
measur
paramount
reduc
spread
health
care
worker
possibl
commun
therefor
world
health
organ
center
diseas
control
prevent
cdc
recommend
contact
airborn
precaut
initi
suspect
case
avian
influenza
human
late
octob
cdc
releas
updat
interim
guidanc
use
mask
respir
health
care
set
tabl
certain
high
risk
procedur
addit
protect
may
consid
given
likelihood
gener
aerosol
particl
may
enhanc
transmiss
tabl
respiratori
protect
worn
along
imperm
gown
face
shield
glove
initi
case
place
neg
pressur
isol
room
air
chang
per
hour
hand
hygien
antibacteri
soap
alcohol
base
washless
gel
standard
appropri
basin
patient
room
season
vaccin
health
care
worker
preform
emphas
order
reduc
likelihood
coinfect
two
stain
influenza
visitor
famili
member
strictli
monitor
access
patient
limit
reduc
likelihood
spread
final
antivir
chemoprophylaxi
avail
health
care
worker
expos
infect
individu
symptomat
worker
taken
duti
workplac
surveil
occur
aggress
measur
risk
health
care
worker
patient
famili
member
reduc
avian
influenza
virus
occur
increas
incid
within
human
popul
reflect
delic
tangl
interact
wildlif
domest
anim
human
diseas
human
limit
conjunct
influenzalik
ill
hpai
caus
mainli
sever
pneumonia
respiratori
failur
death
case
occur
direct
transmiss
infect
poultri
waterfowl
limit
case
human
human
transmiss
treatment
success
na
inhibitor
start
earli
vaccin
develop
underway
immunogen
attenu
viru
prepar
infect
control
measur
mainstay
prevent
diseas
reduct
avian
influenza
virus
may
constitut
part
next
pandem
appropri
knowledg
prevent
treatment
reduc
likelihood
occurr
tabl
high
risk
aerosol
procedur
avian
influenza
noninvas
mechan
ventil
bronchoscopi
humidifi
oxygen
deliveri
nonrebreath
mask
without
expiratori
filter
articl
part
themat
seri
disast
manag
edit
j
christoph
farmer
articl
seri
found
onlin
http
ccforumcomarticl
themeseriesasp
seriesccdisast
